APIs: the flavor of the season in India

Supply chain disruptions, quality concerns and abrupt price hikes have been some of the issues resulting from over-dependency on a single source for supplies of life-saving drugs and other key raw materials. To mitigate risks associated with over-dependency on other nations, India's Health Minister Mansukh Mandaviya says the focus is to build self-reliance and promote the domestic pharmaceutical manufacturing industry, despite the decision to shut down two pharma public sector undertakings and disinvest three others, reports The Pharma Letter’s India correspondent.